ElevateBio

ElevateBio is a technology-driven company founded in 2018 that powers transformative genetic medicines today and aims to sustain this innovation for many decades to come. The Company commercialises its enabling technologies, manufacturing capabilities, and industry-leading expertise through partnerships to accelerate development across a broad spectrum of therapeutic approaches and modalities. The ElevateBio ecosystem combines multiple R&D technology platforms – including Life Edit, a next-generation, full-spectrum gene editing platform; comprehensive cell engineering technologies; and an expanded viral and non-viral therapeutic delivery platform – with BaseCamp®, its end-to-end genetic medicine cGMP manufacturing and process development business, in order to accelerate the discovery and development of advanced therapeutics.

Services include:
- Cell and Gene Therapy
- Drug Substance Manufacturing (API)
- Drug Product Formulation (FDF)
- Research & Development
- Clinical Trial Materials
- Regulatory Services
- Analytical Methods Development

ElevateBio aims to be the dominant engine behind the world's greatest scientific advancements harnessing human cells and genes to alter disease. For more information, visit elevate.bio.